Black Patients Wait Longer for Uterine Cancer Testing, Diagnosis
Black patients are less likely to receive early diagnoses for uterine cancer than other racial and ethnic groups, according to new research.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Unknown Origin & Other Cancer Types |
Black patients are less likely to receive early diagnoses for uterine cancer than other racial and ethnic groups, according to new research.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Breast |
Natera’s Signatera MRD test has met coverage requirements for adjuvant and recurrence monitoring in patients with breast cancer.
Read MorePosted by Andy Lundin | Feb 16, 2023 | Cancer |
Eurofins launched a test that can assess the expansion and persistence of CAR-T therapy in patients with certain leukemia and lymphomas.
Read MorePosted by Andy Lundin | Feb 10, 2023 | Prostate |
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read MorePosted by Andy Lundin | Feb 8, 2023 | Sexually Transmitted Diseases |
Thermo Fisher Scientific launched a PCR test designed to detect several STIs, as well as RNase P, included as a human internal control.
Read More